Global /United States /Healthcare /Biotechnology /SRXH
chevron_leftBack
SRx Health Solutions Inc. logo

SRx Health Solutions Inc.

SRXH
NYSEAMERICAN: SRXH Delayed
0.1149USD -0.5%
As of 15 June 2026, SRx Health Solutions Inc. has a market cap of $41.16M USD, ranking #31943 globally and #4582 in the United States. It ranks #2890 in the Healthcare sector, and #561 in the Biotechnology industry.
Global Rank
31943
Country Rank
4582
Sector Rank
2890
Industry Rank
561
Key Stats
Market Cap
$41.16MUSD
Enterprise Value
$48.63MUSD
Revenue (TTM)
$9.34MUSD
EBITDA (TTM)
-$12.77MUSD
Net Income (TTM)
-$49.64MUSD
EBITDA Margin
-137%
PS Ratio
4.4
PB Ratio
11.5
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Biotechnology
CEO
Kent Cunningham open_in_new
Employees
11
Founded
2013
Website
srxhealth.com/ open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
-0.5% -2.2% -2.5% -23% -69% -94%

News

Loading...

SRXH Analyst Forecasts

Loading...

Markets

Exchange Ticker Price
NYSE American
MIC: XASE
PRIMARY
SRXH
Better Choice Co Inc
ISIN: US08771Y4026
Shares Out.:
590.255M1 Shares Float: 565.821M2
TV:
SA:
YF:
GF:
NQ:
BA:
MS:
0.1149 USD
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About SRx Health Solutions Inc.

SRx Health Solutions Inc., through its subsidiaries, engages in the specialty pharmacy and pet health and wellness businesses in the United States, Taiwan, and internationally. The company offers pet health and wellness products in multiple forms, including kibble, canned food, freeze-dried raw food, treats, and supplements. The company also offers consumer products, including dry food, wet food, treats, and other premium pet products. The company also offers pharmacy services, patient support programs, diagnostic services, and clinical trials. The company was founded in 2013 and is headquartered in North Palm Beach, Florida.

Similar Companies

Industry: Biotechnology (United States)
Name
Market Cap diff.
PE
AMGN
$182.42B
443K%
23.9
GILD
$159.92B
388K%
19.0
NTRA
$27.6B
67K%
-
$26.3B
64K%
20.0
$25.03B
61K%
20.4
MRNA
$18.13B
44K%
-
Industry: Biotechnology (Global)
Name
Market Cap diff.
PE
ARGX
$47.84B
41.39B EUR
116K%
39.9
$44.84B
68.19T KRW
109K%
35.5
CSL
$42.36B
60.27B AUD
103K%
29.3
LONN
$42.3B
33.71B CHF
103K%
37.2
068270
$28.11B
42.76T KRW
68K%
43.8
BNTX
$25.69B
62K%
-
chevron_leftBack